Amgen (AMGN) Tops Q4 EPS by 32c, Raises FY16 Guidnce
Get Alerts AMGN Hot Sheet
Price: $273.01 -0.19%
EPS Growth %: -2.3%
Financial Fact:
Other charges: 23M
Today's EPS Names:
NLY, CP, RUSHA, More
EPS Growth %: -2.3%
Financial Fact:
Other charges: 23M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $2.61, $0.32 better than the analyst estimate of $2.29. Revenue for the quarter came in at $5.54 billion versus the consensus estimate of $5.53 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $10.60-$11.00, versus prior guidance of $10.35-$10.75 and the consensus of $10.66. Amgen sees FY2016 revenue of $22-22.5 billion, versus prior guidance of $21.7-22.3 billion and the consensus of $22.3 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Tops Q1 EPS by 20c; offers guidance
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Alamos Gold (AGI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!